Cleared Traditional

K062379 - COBAS INTEGRA CERULOPLASMIN

K062379 is an FDA 510(k) clearance for COBAS INTEGRA CERULOPLASMIN, manufactured by Roche Diagnostics Corp.. The device is a Class 1 Chemistry device with product code JJY cleared through the Traditional 510(k) pathway after a 169-day FDA review.

K062379 · Roche Diagnostics Corp. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2007
Decision
169d
Days
Class 1
Risk

K062379 is an FDA 510(k) clearance for the COBAS INTEGRA CERULOPLASMIN. Classified as Multi-analyte Controls, All Kinds (assayed) (product code JJY), Class I - General Controls.

Submitted by Roche Diagnostics Corp. (Indianapolis, US). The FDA issued a Cleared decision on January 31, 2007 after a review of 169 days - an extended review cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1660 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Roche Diagnostics Corp. devices

FDA 510(k) Submission Details - K062379

510(k) Number K062379 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 15, 2006
Decision Date January 31, 2007
Days to Decision 169 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
81d slower than avg
Panel avg: 88d · This submission: 169d
Pathway characteristics
Predicate-based equivalence.

JJY Device Classification - Class 1, General Controls

Product Code JJY Multi-analyte Controls, All Kinds (assayed)
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1660
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - JJY Multi-analyte Controls, All Kinds (assayed)

All 569
Devices cleared under the same product code (JJY) and FDA review panel - the closest regulatory comparables to K062379.
AMMONIA/ALCOHOL CONTROL SET
K070504 · Pointe Scientific, Inc., · Apr 2007
TDM CONTROL SET, MODEL CAT# 04521536
K070200 · Roche Diagnostics Corp. · Mar 2007
AUDIT MICROCV LIPIDS LINEARITY SET (LOW)
K070223 · Aalto Scientific, Ltd. · Mar 2007
MISSION TRINITY B
K062674 · Diamond Diagnostics, Inc. · Dec 2006
CLINIQA LIQUID QC CARDIAC MARKER CONTROL SP, LEVELS 1,2, &3
K062916 · Cliniqa Corporation · Oct 2006
AUDIT MICROCV IMMUNOASSAY LINEARITY SET
K062668 · Aalto Scientific, Ltd. · Oct 2006